Great first session to #ASCOQLTY23. @BThomPhD highlights practice delivery changes that can reduce financial toxicity for patients - telehealth, coordinated appointments, standardizing surveillance. Spot on! @ColonCancerDoc
Although circumferential resection margin (CRM) positivity reporting has improved over past decade, ¼ of Commission on Cancer facilities have missingness rates >16%. CRM missingness was associated with missingness in other pathologic measures. https://t.co/UFbPGrFYIb
This issue has the potential to open flood gates - maybe good, maybe bad! Near-complete response following neoadjuvant therapy in rectal cancer: wait a bit longer? https://t.co/GUq6yqCfwA @R_Perez_MD @DrGarciaAguilar @JoshSmithMDPhD@Dr_M_Tejani@ColonCancerDoc
What is the most common type of anesthesia used for colonoscopies?
And what side effects can you expect?
Here, our Dr. Katherine Hagan answers common questions about colonoscopy anesthesia: https://t.co/AetttoeAY0 @katehagan1#ColonCancer#EndCancer
Leadership is not about pulling people to follow your path. It's about shining enough light for them to find their own route.
Bosses aim to wield power. They issue commands to maintain control.
Leaders strive to empower. They delegate authority to unleash potential.
Don’t forget about a proper omental flap. Particularly when based on right gastroepiploic and including all the omentum to the diaphragm, can get great space filling, lymphatic drainage, and avoid morbidity of gluteal or rectus flaps! Does not require high BMI!
@TAMISYoda@DCRjournal APER will never be morbidity free and post RT 1/3 have delayed healing which patients hate (RCT data). So, if radiated then always. Gluteal is easier and doesn’t sacrifice the remaining rectus. No free lunch anywhere here! @DrGarciaAguilar @juliomayol@ColonCancerDoc@cmf2x
Important study 👇 led by @MDAndersonNews#YOCRC program and director @NancyYouMD highlights need for universal germline testing. 1 in 5 #CRC patients <50 yo harbored germline cancer predisposition. Another nearly 1 in 5 with VUS. #OncSurgery
@JohnRTMonsonMD@MDAndersonNews@TAMISYoda@Leo708@ASCRS_1 Still much to learn. 👍 growing recognition lateral node metastases should not be ignored or overlooked. Lateral dissection, whether based on pretreatment findings or selectively based on post treatment findings should be part of the management strategy. #OncSurgery